Researchers have explored the cellular changes that occur in human mammary tissue in lactating and non-lactating women, offering insight into the relationship between pregnancy, lactation and breast cancer.
Experts at the Cancer Research UK Cambridge Centre will receive around £22.5 million over the next five years for their ground-breaking work, as part of the development of a unique chain of cutting-edge research hubs around the UK.
Faulty versions of the BRCA1 and BRCA2 genes are well known to increase the risk of breast cancer in men and women, and in ovarian cancer. Now BRCA1 and BRCA2 have been linked to several other cancers, including those that affect men.
Cancer researchers at Cambridge say the last five years have been among the most exciting times for the advancement of treatment in ovarian cancer, a difficult cancer to treat.
Hear about the research that’s helping to change the story of ovarian cancer and meet some of the women at the centre of the programme, using the links below.
Friday 14 January 2022 – a virtual event about cancer research and clinical trials in Cambridge aimed at patients, carers and anyone with an interest in cancer research.
The Cambridge Cancer Research Hospital (CCRH) project has now had the first stage of its business case (the Strategic Outline Case) approved by the Department for Health and Social Care and NHS England & NHS Improvement.